Syntaxin 3 (STX3) is involved in exocytosis12, 13 and has been reported to promote cancer cell proliferation in breast cancer14 and to predict survival outcome in lung cancer,15 but no study has reported its role in ESCC. Here, STX3 is linked to lung cancer.